Embed this press release by copying the code below:
NASDAQ: ACRS Long Term Investor Alert: Investigation of Potential Wrongdoing at Aclaris Therapeutics, Inc.
NASDAQ: ACRS Long Term Investor Alert: Investigation of Potential Wrongdoing at Aclaris Therapeutics, Inc.